Clinical Trial Update: The Safety and Efficacy of MoodElite T-4003-1 on Improving Mood in a Healthy Adult Population With Mild to Moderate Depressive Symptoms Not Eligible for Therapeutic Intervention [Phase 1, Phase 2]

View source ↗

Summary

A completed Phase 1/2 trial assessing safety and efficacy of MoodElite T-4003-1 for improving mood in adults with mild to moderate depressive symptoms not eligi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Depressive Disorder Primary
• Major Depressive Disorder
• Mood Disorder

Drugs mentioned

• MoodElite T-4003-1 (MoodElite T-4003-1)

Snippet

Sponsor: Chenland Nutritionals Inc. | Conditions: Mood | Phase 1, Phase 2 | Status: COMPLETED